The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.2, 2012-02, pp. : 109-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How can attrition rates be reduced in cancer drug discovery?

By Moreno Lucas Pearson Andrew DJ

Expert Opinion on Drug Discovery, Vol. 8, Iss. 4, 2013-04 ,pp. : 363-368

Informa Healthcare

Access to resources Recommend Favorite

Toxicogenomics in drug safety assessment

By Hewitt Philip Walijew Alexandra

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

Applied Pharmacokinetics in Drug Development: An Overview of Drug Discovery

By Caldwell G.W. Yan Z. Masucci J.A. Hageman W. Leo G. Ritchie D.M.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 2, 2003-01 ,pp. : 117-132

Adis International

Access to resources Recommend Favorite

Compound decomposition: a new drug discovery tool?

By Talaga P.

Drug Discovery Today, Vol. 9, Iss. 2, 2004-01 ,pp. : 51-53

Elsevier

Access to resources Recommend Favorite

Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening

Current Pharmaceutical Design, Vol. 8, Iss. 13, 2002-06 ,pp. : 1137-1154

Bentham Science Publishers

Access to resources Recommend Favorite